JSPR
Price
$3.33
Change
-$0.04 (-1.19%)
Updated
Jul 18 closing price
Capitalization
50.02M
SONN
Price
$6.18
Change
-$1.61 (-20.67%)
Updated
Jul 18 closing price
Capitalization
19.56M
Interact to see
Advertisement

JSPR vs SONN

Header iconJSPR vs SONN Comparison
Open Charts JSPR vs SONNBanner chart's image
Jasper Therapeutics
Price$3.33
Change-$0.04 (-1.19%)
Volume$350.33K
Capitalization50.02M
Sonnet BioTherapeutics Holdings
Price$6.18
Change-$1.61 (-20.67%)
Volume$1.56M
Capitalization19.56M
JSPR vs SONN Comparison Chart in %
Loading...
JSPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SONN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
JSPR vs. SONN commentary
Jul 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JSPR is a Hold and SONN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 20, 2025
Stock price -- (JSPR: $3.33 vs. SONN: $6.18)
Brand notoriety: JSPR and SONN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: JSPR: 45% vs. SONN: 31%
Market capitalization -- JSPR: $50.02M vs. SONN: $19.56M
JSPR [@Biotechnology] is valued at $50.02M. SONN’s [@Biotechnology] market capitalization is $19.56M. The market cap for tickers in the [@Biotechnology] industry ranges from $293.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JSPR’s FA Score shows that 2 FA rating(s) are green whileSONN’s FA Score has 0 green FA rating(s).

  • JSPR’s FA Score: 2 green, 3 red.
  • SONN’s FA Score: 0 green, 5 red.
According to our system of comparison, JSPR is a better buy in the long-term than SONN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

JSPR’s TA Score shows that 5 TA indicator(s) are bullish while SONN’s TA Score has 5 bullish TA indicator(s).

  • JSPR’s TA Score: 5 bullish, 5 bearish.
  • SONN’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, SONN is a better buy in the short-term than JSPR.

Price Growth

JSPR (@Biotechnology) experienced а -5.13% price change this week, while SONN (@Biotechnology) price change was +17.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.49%. For the same industry, the average monthly price growth was +13.01%, and the average quarterly price growth was +34.43%.

Reported Earning Dates

JSPR is expected to report earnings on May 12, 2025.

SONN is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (+2.49% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JSPR($50M) has a higher market cap than SONN($19.6M). SONN YTD gains are higher at: 323.288 vs. JSPR (-84.425). SONN has higher annual earnings (EBITDA): -13.69M vs. JSPR (-81.61M). JSPR has more cash in the bank: 48.8M vs. SONN (2.06M). SONN has less debt than JSPR: SONN (90.4K) vs JSPR (2.59M). SONN has higher revenues than JSPR: SONN (1M) vs JSPR (0).
JSPRSONNJSPR / SONN
Capitalization50M19.6M255%
EBITDA-81.61M-13.69M596%
Gain YTD-84.425323.288-26%
P/E RatioN/A0.29-
Revenue01M-
Total Cash48.8M2.06M2,370%
Total Debt2.59M90.4K2,865%
FUNDAMENTALS RATINGS
SONN: Fundamental Ratings
SONN
OUTLOOK RATING
1..100
49
VALUATION
overvalued / fair valued / undervalued
1..100
81
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
JSPRSONN
RSI
ODDS (%)
Bullish Trend 3 days ago
75%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
66%
Bullish Trend 3 days ago
83%
Momentum
ODDS (%)
Bearish Trend 3 days ago
71%
Bullish Trend 3 days ago
82%
MACD
ODDS (%)
Bearish Trend 3 days ago
65%
N/A
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
75%
Bullish Trend 3 days ago
80%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
75%
Bullish Trend 3 days ago
72%
Advances
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 6 days ago
78%
Declines
ODDS (%)
Bearish Trend 6 days ago
83%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
70%
Bearish Trend 3 days ago
79%
Aroon
ODDS (%)
Bullish Trend 5 days ago
74%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
JSPR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SONN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BENF0.350.03
+10.53%
Beneficient
GEOS10.730.20
+1.90%
Geospace Technologies Corp
NUE140.63-0.12
-0.09%
Nucor Corp
CWAN21.50-0.22
-1.01%
Clearwater Analytics Holdings
MYE14.62-0.28
-1.88%
Myers Industries

JSPR and

Correlation & Price change

A.I.dvisor indicates that over the last year, JSPR has been loosely correlated with AUPH. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if JSPR jumps, then AUPH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JSPR
1D Price
Change %
JSPR100%
-1.19%
AUPH - JSPR
44%
Loosely correlated
-4.85%
AVXL - JSPR
39%
Loosely correlated
-0.72%
ATNF - JSPR
38%
Loosely correlated
+2.73%
APGE - JSPR
36%
Loosely correlated
+0.79%
DSGN - JSPR
36%
Loosely correlated
-1.00%
More

SONN and

Correlation & Price change

A.I.dvisor indicates that over the last year, SONN has been closely correlated with PTHS. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if SONN jumps, then PTHS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SONN
1D Price
Change %
SONN100%
-20.67%
PTHS - SONN
70%
Closely correlated
+0.62%
CLLS - SONN
28%
Poorly correlated
-8.54%
DWTX - SONN
27%
Poorly correlated
+1.47%
JSPR - SONN
26%
Poorly correlated
-1.19%
IGMS - SONN
26%
Poorly correlated
+0.79%
More